After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...

Dr. Falk Pharma, in cooperation with its fully-owned subsidiary Losan Pharma GmbH, a leading contract development and ...

In an exclusive interview with Business Today, D. Sridhar Babu, Minister for Information Technology, Industries and Commerce, ...

The White House has confirmed that the trade deal signed with the EU – which includes an overarching tariff rate of 15% on ...

DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, "Pharma R&D Services Market Report (2024-2029)." This comprehensive ...

According to the European Union, in 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared ...

In this video interview, Kate Gallin Heffernan, life sciences attorney at Epstein Becker Green, advises clinical research ...

Experts say what matters most is how the money is spent to build collaborative ecosystems and thriving innovation ...

The University of Copenhagen is excited to announce XPRIZE Healthspan as Tier 5 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the ...

Opportunities in traditional pharma companies with a focus on domestic formulations and US generic drugs are drying up ...

Ionis Pharmaceuticals (IONS) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to a loss of $0.45 per share a year ago. These ...

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative Vaccines" BOSTON ...